Chordia Therapeutics (190A) · FactRestated
No Dividends Paid
First written in FY2024-Q3. 2 of 4 entries say "Restated". Latest entry: FY2026-H1.
4entries
3years
0from disclosures
How it moved
Same theme, other companies
Continuation of a no-dividend policyA theme 52 companies write about · 36 as a headwind · 0 as a tailwind
33 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 52 companies compared. The sentences above are computed from all 52.Full recordFilings, disclosures and news, newest first
- FY2026-H1RestatedAnnual report
「No per-share dividend is shown because no dividend was paid.」
No dividends were paid during the interim accounting period either. - FY2025-H1RestatedAnnual report
「4. The amount of dividends per share is not stated because no dividends have been paid.」
No dividends were paid during the interim accounting period either. - FY2024SoftenedAnnual report
「The Company has paid no dividends since its establishment. As it also plans to continue conducting R&D activities involving substantial upfront investment, it intends not to pay dividends for the time being and to prioritize securing funds for continued R&D activities.」
While the policy of paying no dividends for the time being remains in place, the Company stated that it will consider paying dividends depending on future earnings and financial conditions. - FY2024-Q3First statedAnnual report
「No per-share dividend is shown because no dividend was paid.」
It was disclosed that no dividends were paid during the period.